THE INGRAM GROUP LLC

Lobbying for LYNCH REGENERATIVE MEDICINE, LLC · biotech company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Tennessee · House · Senate · $40,000.00 income · posted Jan 14, 2026

Lobbying activity 1

Medicare/Medicaid

Issues related to Local Coverage Determinations (LCDs) implementation. Issues related to the Finalized CY 2026 Medicare Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.